These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23133648)
21. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. Streilein JW; Niederkorn JY J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766 [TBL] [Abstract][Full Text] [Related]
22. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID). Ferguson TA; Kaplan HJ Reg Immunol; 1988; 1(1):62-8. PubMed ID: 2978943 [TBL] [Abstract][Full Text] [Related]
23. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells. Kosiewicz MM; Streilein JW J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308 [TBL] [Abstract][Full Text] [Related]
24. The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens. Saban DR; Cornelius J; Masli S; Schwartzkopff J; Doyle M; Chauhan SK; Peck AB; Grant MB Mol Vis; 2008; 14():2435-42. PubMed ID: 19104677 [TBL] [Abstract][Full Text] [Related]
25. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Skelsey ME; Mayhew E; Niederkorn JY Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5242-51. PubMed ID: 14638723 [TBL] [Abstract][Full Text] [Related]
26. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation. Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576 [TBL] [Abstract][Full Text] [Related]
27. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Wilbanks GA; Streilein JW Immunology; 1990 Nov; 71(3):383-9. PubMed ID: 1702748 [TBL] [Abstract][Full Text] [Related]
28. Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. Ashour HM; Niederkorn JY J Immunol; 2006 Dec; 177(12):8331-7. PubMed ID: 17142729 [TBL] [Abstract][Full Text] [Related]
29. Induction of Contrasuppressor Cells and Loss of Immune Privilege Produced by Corneal Nerve Ablation. Neelam S; Mellon J; Wilkerson A; Niederkorn JY Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4738-4747. PubMed ID: 30267096 [TBL] [Abstract][Full Text] [Related]
30. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040 [TBL] [Abstract][Full Text] [Related]
31. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses. Xu Y; Kapp JA Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158 [TBL] [Abstract][Full Text] [Related]
32. Two different regulatory T cell populations that promote corneal allograft survival. Cunnusamy K; Paunicka K; Reyes N; Yang W; Chen PW; Niederkorn JY Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6566-74. PubMed ID: 20702818 [TBL] [Abstract][Full Text] [Related]
33. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438 [TBL] [Abstract][Full Text] [Related]
34. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Li XY; D'Orazio LT; Niederkorn JY Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137 [TBL] [Abstract][Full Text] [Related]
35. Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression. Thompson HS; Harper N; Bevan DJ; Staines NA Autoimmunity; 1993; 16(3):189-99. PubMed ID: 8003614 [TBL] [Abstract][Full Text] [Related]
36. The suppression of hypersensitivity by ocular-induced CD8(+) T cells requires compatibility in the Qa-1 haplotype. Cone RE; Chattopadhyay S; Sharafieh R; Lemire Y; O'Rourke J Immunol Cell Biol; 2009; 87(3):241-8. PubMed ID: 19139762 [TBL] [Abstract][Full Text] [Related]
37. T cell sensitivity to TGF-beta is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber. Cone RE; Chattopadhyay S; Sharafieh R; Lemire Y; O'Rourke J; Flavell RA; Clark RB Int Immunol; 2009 May; 21(5):567-74. PubMed ID: 19325036 [TBL] [Abstract][Full Text] [Related]
38. Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells. Waldrep JC; Kaplan HJ Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1086-92. PubMed ID: 6192107 [TBL] [Abstract][Full Text] [Related]
39. Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. Griffith TS; Brincks EL; Gurung P; Kucaba TA; Ferguson TA J Immunol; 2011 Jan; 186(2):791-8. PubMed ID: 21169546 [TBL] [Abstract][Full Text] [Related]
40. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells. Wang Y; O'Rourke J; Cone RE Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]